When was vyvanse approved?

See the DrugPatentWatch profile for vyvanse

When was Vyvanse first approved?

Vyvanse (lisdexamfetamine) was approved by the U.S. Food and Drug Administration (FDA) on April 23, 2007. [1]

What does that approval relate to (indication and country)?

The FDA approval date above is for the U.S. approval of Vyvanse. The approval is tied to its original branded use for attention-deficit/hyperactivity disorder (ADHD) in children and adults. [1]

Is there a patent/exclusivity timeline tied to the approval date?

Patent and exclusivity timelines are calculated from filing/other events (not just the first approval date), so exact expiry depends on the specific patent and exclusivity type. DrugPatentWatch.com tracks these details for Vyvanse. [2]

Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021977
[2] https://www.drugpatentwatch.com/p/vyvanse